§ 44-790.01 — Covered prescription insulin drug; maximum payment; ensure access; requirements

Nebraska § 44-790.01

• Jurisdiction: Nebraska
• Ch. 44: Insurance

Text

(1) Except as provided in subsection (3) of this section, beginning January 1, 2024, and notwithstanding section 44-3,131 , (a) any individual or group sickness and accident insurance policy or subscriber contract delivered, issued for delivery, or renewed in this state and any hospital, medical, or surgical expense-incurred policy, except for policies that provide coverage for a specified disease or other limited-benefit coverage, and (b) any self-funded employee benefit plan to the extent not preempted by federal law, which provides reimbursement for prescription insulin drugs shall limit the total amount that a covered individual is required to pay for each covered prescription insulin drug on the policy's, contract's, or plan's lowest brand or generic tier to a maximum of thirty-five dollars per thirty-day supply of insulin, regardless of the amount needed.
(2) Nothing in this section prevents a policy, contract, or plan from reducing the total amount that a covered individual is required to pay for each covered prescription insulin drug to an amount less than the maximum specified in subsection (1) of this section.
(3) If, due to a national shortage of an insulin drug, a covered individual cannot access a covered prescription insulin drug on the lowest brand or generic tier of the policy, contract, or plan, the policy, contract, or plan shall ensure access to an insulin drug at a maximum of thirty-five dollars per thirty-day supply, until such time that the national shortage ends to prevent disruptions in patient access to insulin.
(4) For purposes of this section, prescription insulin drug means a prescription drug that contains insulin and is used to treat diabetes.

Legislative History

Source: Laws 2023, LB92, § 86.